Search

Your search keyword '"Mortera-Blanco, Teresa"' showing total 203 results

Search Constraints

Start Over You searched for: Author "Mortera-Blanco, Teresa" Remove constraint Author: "Mortera-Blanco, Teresa"
203 results on '"Mortera-Blanco, Teresa"'

Search Results

3. Patient-specific MDS-RS iPSCs define the mis-spliced transcript repertoire and chromatin landscape of SF3B1-mutant HSPCs

4. Pseudouridine-modified tRNA fragments repress aberrant protein synthesis and predict leukaemic progression in myelodysplastic syndrome

5. Competition of dual SF3B1mt clones in MDS-RS is associated with distinct RNA mis-splicing in hematopoietic stem cells

6. Early transfusion patterns improve the Molecular International Prognostic Scoring System (IPSS-M) prediction in myelodysplastic syndromes

7. Data from Erythroid Differentiation Enhances RNA Mis-Splicing in SF3B1-Mutant Myelodysplastic Syndromes with Ring Sideroblasts

8. Main supplemental file from Erythroid Differentiation Enhances RNA Mis-Splicing in SF3B1-Mutant Myelodysplastic Syndromes with Ring Sideroblasts

9. Data S5 from Erythroid Differentiation Enhances RNA Mis-Splicing in SF3B1-Mutant Myelodysplastic Syndromes with Ring Sideroblasts

11. Development of an ex vivo three dimensional (3-D) model of acute myeloid leukaemia (AML)

12. Erythroid differentiation enhances RNA mis-splicing in SF3B1-mutant myelodysplastic syndromes with ring sideroblasts

13. Supplementary Figure S7 from Integrated Genomic and Transcriptomic Analysis Improves Disease Classification and Risk Stratification of MDS with Ring Sideroblasts

14. Supplementary Results S1 from Integrated Genomic and Transcriptomic Analysis Improves Disease Classification and Risk Stratification of MDS with Ring Sideroblasts

15. Supplementary Table S1 from Integrated Genomic and Transcriptomic Analysis Improves Disease Classification and Risk Stratification of MDS with Ring Sideroblasts

16. Data from Integrated Genomic and Transcriptomic Analysis Improves Disease Classification and Risk Stratification of MDS with Ring Sideroblasts

18. P713: EXPLORING CLONAL COMPETITION THROUGH 12-YEAR FOLLOW-UP OF AN MDS-RS PATIENT WITH DUAL SF3B1 MUTATIONS

19. Integrated Genomic and Transcriptomic Analysis Improves Disease Classification and Risk Stratification of MDS with Ring Sideroblasts

20. Erythroid differentiation intensifies RNA mis-splicing inSF3B1-mutant myelodysplastic syndromes with ring sideroblasts

21. Myelodysplastic Syndromes Are Propagated by Rare and Distinct Human Cancer Stem Cells In Vivo

22. Long-Term Clonal Inversion in an MDS-RS Case with Dual SF3B1 Mutations

23. Transfusion Patterns during Early Follow-up Predict Overall Survival Independently of IPSS-M in Patients with Myelodysplastic Syndromes

25. Transfusion Patterns during Early Follow-up Predict Overall Survival Independently of IPSS-M in Patients with Myelodysplastic Syndromes

28. Whole Transcriptome Analysis Identifies Distinct Gene Expression Profiles between SF3B1mut and SF3B1 wt Myelodysplastic Syndrome with Ring Sideroblasts

29. Isogenic MDS-RS Patient-Derived iPSCs Define the Mis-Spliced Transcript Repertoire and Chromatin Landscape of SF3B1-Mutant Hematopoietic Stem/Progenitor Cells

30. Integrative Analysis of Primary SF3B1 mt Ring Sideroblasts Provides Fundamental Insights into MDS-RS Pathogenesis and Dyserythropoiesis

32. A three-dimensional in vitro model of erythropoiesis recapitulates erythroid failure in myelodysplastic syndromes

33. Myelodysplastic Syndromes Are Propagated by Rare and Distinct Human Cancer Stem Cells In Vivo

34. Perturbed hematopoietic stem and progenitor cell hierarchy in myelodysplastic syndromes patients with monosomy 7 as the sole cytogenetic abnormality

35. Aberrant splicing of genes involved in haemoglobin synthesis and impaired terminal erythroid maturation inSF 3B1mutated refractory anaemia with ring sideroblasts

36. Development of an Ex Vivo Three Dimensional (3-D) Model of Acute Myeloid Leukaemia (AML)

37. Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo.

39. Diverse Genetic Lesions In Myelodysplastic Syndromes Originate Exclusively In Rare MDS Stem Cells

41. Erythropoiesis In SF3B1 Mutated RARS Is Disrupted During Terminal Erythroid Maturation

46. Stem cell bioprocessing: fundamentals and principles

47. Stem cell bioprocessing: fundamentals and principles

49. Integrative Analysis of Primary SF3B1 mtRing Sideroblasts Provides Fundamental Insights into MDS-RS Pathogenesis and Dyserythropoiesis

50. Whole Transcriptome Analysis Identifies Distinct Gene Expression Profiles between SF3B1mutand SF3B1 wtMyelodysplastic Syndrome with Ring Sideroblasts

Catalog

Books, media, physical & digital resources